European Companies Search Engine
Managing Director: Tilman Fritsch, Wolf-Dieter Grimm · Shareholder agreement Hrb29 Jul 2016 German Trade Register Announcements, Germany
Overview
Text
HRB 10717: Institut für molekulare Diagnostik und innovative Therapie - Molthera - GmbH,
Unnamed street ??, 58452 Witten, Germany
. The shareholders' meeting of May 11, 2016 decided to amend the partnership agreement in Section 3 and with it to increase the share capital by EUR 1,250.00. In addition, Paragraphs 5 (transfer and inheritance of shares), 7 (remuneration of the directors), 8 (shareholders' meeting) and 20 (advisory board) of the partnership agreement were amended. EUR 26,250.00. Appointed as Managing Director: Prof. Dr. Fritsch, Tilman, Bayerisch Gmain, *??.??.????, with the power to enter into legal transactions on behalf of the company in its own name or as a representative of a third party. Appointed as Managing Director upon modification: Prof. Dr. Grimm, Wolf-Dieter, Witten, *??.??.????, authorized to enter into legal transactions on behalf of the company with the authority to do legal transactions in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut für molekulare Diagnostik und innovative Therapie - Molthera - GmbH, Bayerisch Gmain, Germany.
